Preparation of T-cell and T-cell membrane for use in prevention and treatment of autoimmune diseases
US5114721A · kind A · utility
62Cited by
4References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 15, 1989 |
| Grant date | May 19, 1992 |
| Priority date | — |
| Expiry date | Mar 15, 2009 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceutical preparations are provided for preventing or treating autoimmune diseases in which the active principle is activated T-lymphocyte cells, specific for the autoimmune disease to be treated, which cells have been treated by incubation with a photoactivatable psoralen cross-linking agent, such as 8-methoxypsoralen, and then photoactivated. The active principle may also be the membrane fraction of such cells. Such preparations may be formulated into pharmaceutical compositions and administered to prevent or treat autoimmune disesases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.